These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 6336423)

  • 1. Synthesis of thromboxane B2 and prostaglandin F2 alpha by human platelets after contact with biomaterials used in vascular surgery.
    Pizzoferrato A; D'Addato M; Cenni E; Curti T; Cavedagna D; Tarabusi C; Cifiello B
    Life Support Syst; 1983; 1 Suppl 1():251-4. PubMed ID: 6336423
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclooxygenase dependent formation of 8-iso-prostaglandin F2 alpha by human platelets.
    Pratico D; Lawson JA; Fitzgerald GA
    Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():229-31. PubMed ID: 7732840
    [No Abstract]   [Full Text] [Related]  

  • 3. Formation of 8-iso-prostaglandin F2 alpha by human platelets.
    Pratico D; Reilly M; Lawson J; Delanty N; FitzGerald GA
    Agents Actions Suppl; 1995; 45():27-31. PubMed ID: 7717189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variation in cyclooxygenase 1: effects on response to aspirin.
    Halushka MK; Walker LP; Halushka PV
    Clin Pharmacol Ther; 2003 Jan; 73(1):122-30. PubMed ID: 12545150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Venous prostacycline synthesis and plasma thromboxane B2 after low-dose aspirin].
    Kaliman J; Cromwell M; Sinzinger H
    Wien Klin Wochenschr; 1983 Sep; 95(17):615-7. PubMed ID: 6359724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thromboxane synthesis in hypercholesterolemic platelets--on the mechanism of increased thromboxane synthesis.
    Kawaguchi H
    Hokkaido Igaku Zasshi; 1983 May; 58(3):292-309. PubMed ID: 6618425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of the thromboresistance of Dacron combined with various polyurethanes.
    Leake DL; Cenni E; Cavedagna D; Stea S; Ciapetti G; Pizzoferrato A
    Biomaterials; 1989 Sep; 10(7):441-4. PubMed ID: 2529915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methodological assessment and applications of a radioimmunoassay for thromboxane (TxB2) to measurement of TxB2 release by platelets.
    Giannessi D; De Caterina R; Gazzetti P; Bernini W; Masini S; Zucchelli GC
    J Nucl Med Allied Sci; 1982; 26(1):25-33. PubMed ID: 7108634
    [No Abstract]   [Full Text] [Related]  

  • 9. Enzyme immunoassay of thromboxane B2 using immobilized hapten and enzyme amplification.
    Houtz P; Tai HH
    Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():678-83. PubMed ID: 2526560
    [No Abstract]   [Full Text] [Related]  

  • 10. North Karelian study: changes in dietary fat reduce thromboxane B2 formation by platelets only in male subjects--preliminary report.
    Tremoli E; Petroni A; Galli C; Paoletti R; Puska P; Dougherty R; Iacono J
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():203-7. PubMed ID: 6221594
    [No Abstract]   [Full Text] [Related]  

  • 11. Partial agonism of prostaglandin H2 analogs and 11-deoxy-prostaglandin F2 alpha to thromboxane-sensitive preparations.
    Jones RL; Wilson NH
    Adv Prostaglandin Thromboxane Res; 1980; 6():467-75. PubMed ID: 7386280
    [No Abstract]   [Full Text] [Related]  

  • 12. An antithrombotic agent, NQ301, inhibits thromboxane A2 receptor and synthase activity in rabbit platelets.
    Jin YR; Cho MR; Lee KS; Lee JJ; Lim Y; Han XH; Oh KW; Hong JT; Yoo HS; Yun YP
    Basic Clin Pharmacol Toxicol; 2005 Sep; 97(3):162-7. PubMed ID: 16128910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An investigation into vascular prosthesis modified with an electron beam.
    Lowkis B; Szymonowicz M; Rutkowski J
    Polim Med; 1997; 27(3-4):19-26. PubMed ID: 9513250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thromboxane synthase inhibitors suppress more effectively the aggregation of thromboxane receptor-desensitized than that of normal platelets: role of adenylylcyclase up-regulation.
    Vezza R; Nenci GG; Gresele P
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1497-505. PubMed ID: 8531121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of polyester vascular prostheses on synthesis TNF-alpha, IFN-gamma and NO by human peripheral blood leukocytes--in vitro].
    Zywicka B; Czarny A; Zaczyńska E; Pielka S; Solski L
    Polim Med; 2005; 35(3):3-9. PubMed ID: 16440892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development of the vascular prosthesis research].
    Zhu A; Shen J
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2003 Sep; 20(3):537-40. PubMed ID: 14565034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thromboxane B2 production and lipid peroxidation in human blood platelets.
    Best LC; Jones PB; McGuire MB; Russell RG
    Adv Prostaglandin Thromboxane Res; 1980; 6():297-9. PubMed ID: 7386271
    [No Abstract]   [Full Text] [Related]  

  • 18. Blood changes and enhanced thromboxane and 6-keto prostaglandin F1 alpha production in experimental acute Plasmodium bergei infection in hamsters.
    Essien EM; Arnout J; Deckmyn H; Vermylen J; Verstraete M
    Thromb Haemost; 1984 Jul; 51(3):362-5. PubMed ID: 6388013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of PAF on the metabolization of arachidonic acid by human blood platelets.
    Ostermann G; Block HU; Till U
    Biomed Biochim Acta; 1984; 43(8-9):S323-6. PubMed ID: 6440547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arachidonic acid metabolism in the neonatal platelet.
    Stuart MJ; Allen JB
    Pediatrics; 1982 Jun; 69(6):714-8. PubMed ID: 6804924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.